Return on investment in disease management: A review

Ronnie Goetzel, Ronald J. Ozminkowski, Victor G. Villagra, Jennifer Duffy

Research output: Contribution to journalArticle

Abstract

The results of 44 studies investigating financial impact and return on investment (ROI) from disease management (DM) programs for asthma, congestive heart failure (CHF), diabetes, depression, and multiple illnesses were examined. A positive ROI was found for programs directed at CHF and multiple disease conditions. Some evidence suggests that diabetes programs may save more than they cost, but additional studies are needed. Results are mixed for asthma management programs. Depression management programs cost more than they save in medical expenses, but may save money when considering productivity outcomes.

Original languageEnglish (US)
Pages (from-to)1-19
Number of pages19
JournalHealth Care Financing Review
Volume26
Issue number4
StatePublished - Jun 2005
Externally publishedYes

Fingerprint

Disease Management
Asthma
Heart Failure
Disease
Costs and Cost Analysis
management
chronic illness
costs
money
illness
productivity
evidence

ASJC Scopus subject areas

  • Nursing(all)
  • Health(social science)
  • Health Professions(all)

Cite this

Goetzel, R., Ozminkowski, R. J., Villagra, V. G., & Duffy, J. (2005). Return on investment in disease management: A review. Health Care Financing Review, 26(4), 1-19.

Return on investment in disease management : A review. / Goetzel, Ronnie; Ozminkowski, Ronald J.; Villagra, Victor G.; Duffy, Jennifer.

In: Health Care Financing Review, Vol. 26, No. 4, 06.2005, p. 1-19.

Research output: Contribution to journalArticle

Goetzel, R, Ozminkowski, RJ, Villagra, VG & Duffy, J 2005, 'Return on investment in disease management: A review', Health Care Financing Review, vol. 26, no. 4, pp. 1-19.
Goetzel R, Ozminkowski RJ, Villagra VG, Duffy J. Return on investment in disease management: A review. Health Care Financing Review. 2005 Jun;26(4):1-19.
Goetzel, Ronnie ; Ozminkowski, Ronald J. ; Villagra, Victor G. ; Duffy, Jennifer. / Return on investment in disease management : A review. In: Health Care Financing Review. 2005 ; Vol. 26, No. 4. pp. 1-19.
@article{33ac85b3dbec441788d073debbcc7257,
title = "Return on investment in disease management: A review",
abstract = "The results of 44 studies investigating financial impact and return on investment (ROI) from disease management (DM) programs for asthma, congestive heart failure (CHF), diabetes, depression, and multiple illnesses were examined. A positive ROI was found for programs directed at CHF and multiple disease conditions. Some evidence suggests that diabetes programs may save more than they cost, but additional studies are needed. Results are mixed for asthma management programs. Depression management programs cost more than they save in medical expenses, but may save money when considering productivity outcomes.",
author = "Ronnie Goetzel and Ozminkowski, {Ronald J.} and Villagra, {Victor G.} and Jennifer Duffy",
year = "2005",
month = "6",
language = "English (US)",
volume = "26",
pages = "1--19",
journal = "Health Care Financing Review",
issn = "2159-0354",
publisher = "Centers for Medicare & Medicaid Services' Office of Research, Development & Information",
number = "4",

}

TY - JOUR

T1 - Return on investment in disease management

T2 - A review

AU - Goetzel, Ronnie

AU - Ozminkowski, Ronald J.

AU - Villagra, Victor G.

AU - Duffy, Jennifer

PY - 2005/6

Y1 - 2005/6

N2 - The results of 44 studies investigating financial impact and return on investment (ROI) from disease management (DM) programs for asthma, congestive heart failure (CHF), diabetes, depression, and multiple illnesses were examined. A positive ROI was found for programs directed at CHF and multiple disease conditions. Some evidence suggests that diabetes programs may save more than they cost, but additional studies are needed. Results are mixed for asthma management programs. Depression management programs cost more than they save in medical expenses, but may save money when considering productivity outcomes.

AB - The results of 44 studies investigating financial impact and return on investment (ROI) from disease management (DM) programs for asthma, congestive heart failure (CHF), diabetes, depression, and multiple illnesses were examined. A positive ROI was found for programs directed at CHF and multiple disease conditions. Some evidence suggests that diabetes programs may save more than they cost, but additional studies are needed. Results are mixed for asthma management programs. Depression management programs cost more than they save in medical expenses, but may save money when considering productivity outcomes.

UR - http://www.scopus.com/inward/record.url?scp=24144442442&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24144442442&partnerID=8YFLogxK

M3 - Article

C2 - 17288065

AN - SCOPUS:24144442442

VL - 26

SP - 1

EP - 19

JO - Health Care Financing Review

JF - Health Care Financing Review

SN - 2159-0354

IS - 4

ER -